ERBB2 and lung cancer: Molecular alterations such as EGFR mutations, ALK rearrangements, ROS1 rearrangements, RET rearrangements, NTRK fusions, MET mutations, KRAS mutations, BRAF V600E mutations, and HER2 mutations are the contributing factors that underlie the aggressiveness of lung cancer.